Agroaceite, a subsidiary of AgroAmerica Tropical Oil Holding Corp. is Awarded the Community Impact RSPO Excellence Award 2019
20.11.2019 19:31:00 EET | Business Wire | Press release
Agroaceite, a subsidiary of AgroAmerica, was awarded the Community Impact RSPO Excellence Award 2019 for the implementation of the "Human Development Center" project (HDC).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191120005702/en/
Agroaceite, a subsidiary of AgroAmerica Tropical Oil Holding Corp. was awarded the Community Impact RSPO Excellence Award 2019 for the implementation of the "Human Development Center" project (HDC). The subsidiary has donated 10ha of plantations for the construction of the project that is comprised of a Medical Clinic and school for children of workers in Southwestern Guatemala. "It reflects the company's comprehensive vision to provide access to high-quality education & health coverage," Gustavo Bolaños -AgroAmerica COO- (Photo: Business Wire)
The HDC project is based on the Sustainable Development Goals ; and is executed by Agroaceite, a subsidiary of AgroAmerica Tropical Oil Holding Corp; which has donated 10ha of plantations for the construction of the project that is comprised of a Medical Clinic and school for children of workers:
• Medical Clinic: Conducted in partnership with the University of Colorado to promote integral health access. It opened in 2014 and has impacted more than 27 thousand patients in the Southwestern region of Guatemala. It also runs community programs, in which 3,343 children and 1,977 women have participated, to reduce maternal and infant mortality and improve the nutritional status of the area.
• School for children of workers: Established to raise the academic level of the area, the school has obtained regional recognition for academic performance and pedagogical methodology.
"It reflects the company's comprehensive vision to provide access to high-quality education & health coverage," Gustavo Bolaños -AgroAmerica COO-.
With more than 4,000 members from 92 countries around the world, the RSPO organized, for the first time, the RSPO 2019 Excellence Awards Ceremony to recognize their member’s contributions to sustainable production with practices that go beyond the regulations standards.
The award was presented during the seventeenth Annual RSPO Conference -RT17- held in Bangkok, Thailand. A jury of experts in the palm oil and sustainability sector evaluated RSPO member’s projects in 5 categories: Human Rights and Labour Initiative, Conservation Leadership, Smallholder Impact Programme, Community Impact, and Outstanding Achievement.
About AgroAmerica Tropical Oil Holding Corp.:
It is AgroAmerica’s business unit that engages in the production and marketing of Tropical Oil products.
AgroAmerica is committed to contributing to the well being of people through innovation and technological investment for the development of products, services, programs and projects that promote welfare in the company’s stakeholders.
Visit us: https://agroamerica.com/en/
----------------------------------------------------------------
About Agroaceite:
Agroaceite is the fourth company in the world, the third in Latin America, and the first in Central America to obtain the RSPO Next certification, which includes several advanced criteria that exceed the RSPO standard.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191120005702/en/
Contact information
Javier Aguirre
Corporate Director
comunicacion@agroamerica.com
(502) 2420-9600
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 04:00:00 EEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe ’s Coverage of ESCMID Global Congress 202617.7.2026 04:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 01:00:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-treat, high-impact sites, including the scalp, nails, palms and soles, compared with placebo.1-5 These data build on the topline results from the Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled LATITUDE PsO 3001 and 3002 studies.2,6 In those studies, about 70% of patients treated with zasocitinib achieved static Physician Global Assessment (sPGA) 0/1 (clear or almost clear skin) at week 16, with a significantly greater Psoriasis Area and Severity Index (PASI) 75 response rate seen as early as w
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance17.7.2026 00:36:00 EEST | Press release
The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful placement, Merz has further diversified its funding base by
The Estée Lauder Companies Appoints Madeleine Boyd as Senior Vice President, Global Brand Communications16.7.2026 23:22:00 EEST | Press release
The Estée Lauder Companies Inc. (NYSE: EL) today announced the appointment of Madeleine Boyd as Senior Vice President, Global Brand Communications, effective July 20, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716738393/en/ Photo by Esteban La Tessa As part of the company’s continued efforts to strengthen how its brands better connect with consumers, Ms. Boyd will establish and lead a newly integrated Global Brand Communications team. In this role, she will ensure the company’s diverse portfolio is anchored by a cohesive enterprise communications strategy, while accelerating bold, consumer-first storytelling that drives earned media, cultural relevance, and brand desirability. She will also strengthen creator engagement, helping the company’s brands gain attention where culture is being shaped. Ms. Boyd brings extensive experience spanning brand strategy, communications, consumer engagement, and cultural insight
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom